LeonaBio, Inc. Interest and Other Income
LeonaBio, Inc. (LONA) reported Interest and Other Income of $987.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2022-11-10
- LeonaBio, Inc. interest and other income for the quarter ending 2022-09-30 was $987.00K, a 1233.78% increase year-over-year.
- LeonaBio, Inc. interest and other income for the quarter ending 2022-06-30 was $493.00K, a 566.22% increase year-over-year.
- LeonaBio, Inc. interest and other income for the quarter ending 2022-03-31 was $175.00K, a 108.33% increase year-over-year.
- LeonaBio, Inc. interest and other income for the quarter ending 2021-12-31 was $105.00K, a 32.91% increase year-over-year.
- LeonaBio, Inc. interest and other income for fiscal 2021 was $337.00K, a 171.77% increase from fiscal 2020.
- LeonaBio, Inc. interest and other income for fiscal 2020 was $124.00K, a 143.14% increase from fiscal 2019.
- LeonaBio, Inc. interest and other income for fiscal 2019 was $51.00K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2022-09-30 | $987.00K 10-Q · filed 2022-11-10 | $1.48M derived: sum of 2 quarters · filed 2022-11-10 | $1.66M 10-Q · filed 2022-11-10 | $1.76M derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | $493.00K 10-Q · filed 2022-08-15 | $668.00K 10-Q · filed 2022-08-15 | $773.00K derived: sum of 3 quarters · filed 2022-08-15 | $847.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-03-31 | $175.00K 10-Q · filed 2022-05-12 | $280.00K derived: sum of 2 quarters · filed 2022-05-12 | $354.00K derived: sum of 3 quarters · filed 2022-11-10 | $428.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $179.00K derived: sum of 2 quarters · filed 2022-11-10 | $253.00K derived: sum of 3 quarters · filed 2022-11-10 | $337.00K 10-K · filed 2022-03-28 |
| 2021-09-30 | $74.00K 10-Q · filed 2022-11-10 | $148.00K derived: sum of 2 quarters · filed 2022-11-10 | $232.00K 10-Q · filed 2022-11-10 | $311.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $74.00K 10-Q · filed 2022-08-15 | $158.00K 10-Q · filed 2022-08-15 | $237.00K derived: sum of 3 quarters · filed 2022-08-15 | $272.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $84.00K 10-Q · filed 2022-05-12 | $163.00K derived: sum of 2 quarters · filed 2022-05-12 | $198.00K derived: sum of 3 quarters · filed 2022-05-12 | $202.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $114.00K derived: sum of 2 quarters · filed 2022-03-28 | $118.00K derived: sum of 3 quarters · filed 2022-03-28 | $124.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | $35.00K 10-Q · filed 2021-11-10 | $39.00K derived: sum of 2 quarters · filed 2021-11-10 | $45.00K 10-Q · filed 2021-11-10 | $52.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $4.00K 10-Q · filed 2021-08-16 | $10.00K 10-Q · filed 2021-08-16 | $17.00K derived: sum of 3 quarters · filed 2021-08-16 | $29.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $6.00K 10-Q · filed 2021-05-13 | $13.00K derived: sum of 2 quarters · filed 2021-05-13 | $25.00K derived: sum of 3 quarters · filed 2021-05-13 | |
| 2019-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $19.00K derived: sum of 2 quarters · filed 2021-03-25 | $51.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $12.00K 10-Q · filed 2020-11-12 | $44.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |